Get Your Own Businessabc AI Visibility ID
Boost AI visibility, credibility, and discoverability
Founded in 2002, Ambit Biosciences is focused on discovering and developing small molecule drugs for treating cancer and autoimmune diseases. Ambit is a wholly owned subsidiary of Tokyo-based Daiichi Sankyo, and has become a leader in developing novel therapies in these areas.
